Sign up with us for updates

Please sign up to be notified when this website adds new services and resources.

Sign Up Now
Text Zoom
 

PrintMOA

Rituxan selectively targets only CD20+ B cells2—not the entire immune system


CD20 is not found on stem cells, pro-B cells, normal plasma cells, or other normal tissues2
Rituxan selectively targets CD20+ B cells

B-cells are believed to contribute to the immune processes that lead to inflammation and joint damage2

B-cell activity contributes to inflammation and joint damage in RA

Potential roles of the immune process in the pathogenesis of RA

B cells are implicated in the production of cytokines16

  • IL-1, TNF, IL-6

Osteoclast activity and bone erosion

  • In some models, IL-1, TNF, and IL-6, as well as other factors, enhance RANKL
  • RANKL mediates osteoclastogenesis

Also in this section:

Learn about the role of B cells in RA

 

Next The Role of B Cells in RA

REFERENCES

2.Rituxan [package insert]. South San Francisco, CA: Biogen Idec, Inc. and Genentech, Inc.; 2007.
16.Lund FE, Garvy BA, Randall TD, Harris DP. Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. Curr Dir Autoimmun. 2005;8:25-54.